Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04621279 · ClinicalTrials.gov registry record
Cool Prime Comparative Effectiveness Study for Mild HIE
A clinical trial of Mild Hypoxic Ischemic Encephalopathy of Newborn, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 460
- Enrollment target
- 1
- Study location
NCT04621279 is a study of Mild Hypoxic Ischemic Encephalopathy of Newborn that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 460 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04621279, a study of Mild Hypoxic Ischemic Encephalopathy of Newborn, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 460 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine effectiveness of therapy to improve neurodevelopmental outcomes in infants with mild HIE. To determine the adverse effects of Therapeutic Hypothermia (TH) in mild HIE on the neonate and his/her family. Determine heterogeneity of the treatment effect across key subgroups obtained in the first 6 hours after birth prior to the decision to initiate therapy.
Conditions Studied
Interventions
- PROCEDURE Normothermia
- PROCEDURE Whole body therapeutic hypothermia
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 460 participants |
| Start Date | 2023-07-19 |
| Est. Completion | 2029-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04621279
The ClinicalTrials.gov registry entry for NCT04621279 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 460 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mild Hypoxic Ischemic Encephalopathy of Newborn appearing as the primary indexed condition, and to 2 interventions - of which Normothermia is the first listed.
NCT04621279 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04621279 about?
NCT04621279 is a clinical study titled "Cool Prime Comparative Effectiveness Study for Mild HIE". To determine effectiveness of therapy to improve neurodevelopmental outcomes in infants with mild HIE. To determine the adverse effects of Therapeutic Hypothermia (TH) in mild HIE on the neonate and his/her family. Determine heterogeneity of the treatment effect across key subgroups obtained in the ...
What is the current status of trial NCT04621279?
This trial is currently recruiting. The enrollment target is 460 participants. The study started on 2023-07-19. Estimated completion is 2029-01-01.
What conditions does trial NCT04621279 study?
This clinical trial studies the following conditions: Mild Hypoxic Ischemic Encephalopathy of Newborn.
What interventions are being tested in trial NCT04621279?
The interventions under investigation include: Normothermia (PROCEDURE), Whole body therapeutic hypothermia (PROCEDURE).
Who is sponsoring clinical trial NCT04621279?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04621279 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.